key: cord-0733203-nhqi7ojs authors: Eklöv, Karolina; Nygren, Jonas; Bringman, Sven; Löfgren, Jenny; Sjövall, Annika; Nordenvall, Caroline; Everhov, Åsa H. title: Colon cancer treatment in Sweden during the COVID‐19 pandemic: A nationwide register‐based study date: 2022-04-19 journal: Colorectal Dis DOI: 10.1111/codi.16129 sha: d64b44293de508661135096c8a3222ecb7dfe115 doc_id: 733203 cord_uid: nhqi7ojs AIM: The COVID‐19 pandemic has reduced the capacity to diagnose and treat cancer worldwide due to the prioritization of COVID‐19 treatment. The aim of this study was to investigate treatment and outcomes of colon cancer in Sweden before and during the COVID‐19 pandemic. METHODS: In an observational study, using the Swedish Colorectal Cancer Registry, we included (i) all Swedish patients diagnosed with colon cancer, and (ii) all patients undergoing surgery for colon cancer, in 2016–2020. Incidence of colon cancer, treatments and outcomes in 2020 were compared with 2019. RESULTS: The number of colon cancer cases in Sweden in April–May 2020 was 27% lower than the previous year, whereas no difference was observed on an annual level (4,589 vs. 4,763 patients [−4%]). Among patients with colon cancer undergoing surgery in 2020, the proportion of resections was 93 vs. 94% in 2019, with no increase in acute resections. Time from diagnosis to elective surgery decreased (29 days vs. 33 days in 2020 vs. 2019). In 2020, more patients underwent a two‐stage procedure with a diverting stoma as first surgery (6.1%) vs. (4.4%) in 2019 (p = 0.0020) and more patients were treated with preoperative chemotherapy (5.1%) vs. (3,5%) 2019 (p = 0.0016). The proportion of patients that underwent laparoscopic surgery increased from 54% to 58% (p = 0.0017) There were no differences in length of stay, surgical complications, reoperation, ICU‐stay or 30‐day mortality between the years. CONCLUSION: Based on nationwide annual data, we did not observe adverse effects of the COVID‐19 pandemic on colon cancer treatment and short time outcomes in Sweden. There is a scarcity in data regarding factual outcomes for colorectal cancer patients during the pandemic, with the majority of publications being recommendations [3] [4] [5] , audits [6] , surveys [3, 7] and case reports [8] . A few population-based studies have been published, reporting disruptions in the management of colorectal cancer in England [9] , Korea [10] , and Spain [11] . Also in Sweden, the pandemic put the healthcare system under severe strain, with tens of thousands of operations being postponed [12] . The Swedish Cancer Register has reported a 12% reduction of cancer cases March-August 2020 compared to 2019 [13] but there are, to date, no reports on how colon cancer treatment was affected by the pandemic. The aim of this study was to assess colon cancer incidence, treatment and outcomes for year 2020 compared to the preceeding 4 years, with focus on differences between 2019 and 2020. In this observational population-based cohort study we report incidence, stage, treatment, and short-term outcomes for colon cancer in Sweden 2016-2020. We used the RECORD checklist [14] for the report. Sweden is a high-income country with a population of 10 millions in 2020. Healthcare is mainly tax-funded with universal access to care [15] . The first wave of the COVID-19 pandemic peaked in April-May 2020, and the second in October-December the same year. Screening for colorectal cancer with stool test, applied in some regions, was paused from May to August [16] , and surgery for premalignant and benign conditions postponed. Temporary guidelines for colorectal cancer surgery were established 3 April 2020 with recommendations in three different scenarios of escalating COVID-19 [17] . The Swedish Colorectal Cancer Registry (SCRCR) was used as data source. This register has extensive information on patient characteristics, pre-and postoperative tumour staging, tumour location, surgical and oncological treatment and recurrences for colon cancer nationwide since 2007 [18, 19] All statistical tests were two-sided, and p < 0.05 was considered statistically significant. The number of diagnosed cases of colon cancer in April and May was 27% lower in 2020 than in 2019, but increased over the following months ( Figure 1 ). In 2020, 4589 patients were diagnosed with colon cancer, corresponding to an incidence proportion of 0.044% (0.044%-0.047% in 2016-2019; Table 1 ). The patients' age, sex, and tumour locations were similar between the years. The incidence of cT4 tumours increased from The number of interventions for colon cancer (including all procedures, e.g., polypectomy and nonresection surgery) was at its lowest point in May 2020 but the annual number was similar to previous years ( Figure 2 ). The number of operations was 3,964 for year 2020 and 4,016 for year 2019 with similar proportions of resection surgery over calendar years (93% in 2020 vs. 94% 2019; Table 2 ). We Our study shows that despite a reduction in performed surgery during the first wave of COVID-19 in Sweden in April-May 2020 this reduction was compensated for in June to December, and thus colon cancer treatment over the entire year was largely similar to 2019. We observed a change in treatment with more preoperative diverting ostomies and more preoperative oncological treatment, and an increase in the proportion of laparoscopic surgery. in March-April 2020 but were back to preshutdown levels over the following months [22] . In Sweden there were 27% fewer colon cancer patients diagnosed during April-May 2020 compared to the year before, but this rapidly caught up during the rest of the year. We did not observe any significant changes in surgical treatment of colon cancer in Sweden in year 2020, apart from an increase in the proportion of patients receiving a diverting stoma prior to resection surgery (6.1% compared to 4.4% the year before). More ostomies instead of anastomoses compared to the prepandemic period has also been reported from CovidSurg Collaborative, probably due to a wish to reduce complications [23] . In Sweden in 2020, proportionally more patients were diagnosed with locally advanced tumours, which also could explain the increase in use of preoperative diverting stoma. The proportion of patients who were treated with laparoscopic surgery increased from 54% to 58%, contrary to England [9] and Korea [10] , who reported a decline in procedures performed with the minimally invasive technique during the COVID-19 pandemic. In the international survey from covidsurg Collaborative, the proportion of laparoscopic surgeries were comparable to the Swedish numbers (57.2%) [23] . The increase in laparascopic surgery may be due to a general trend and not connected to COVID-19, although without the pandemic the increase might have been even greater. Concerns have been raised that diagnostic delay due to the COVID-19 pandemic may decrease resectability in colorectal cancer, but we found no evidence of this occurring in Sweden. In the present study, more patients were diagnosed in stage cT4 in 2020 compared with 2019, but this trend was also seen during the preceding years and can be explained by a smaller proportion of unstaged patients. It is possible that the relative increase in proportion of cT4 tumours was due to a reduction of cases with less advanced tumours, and therefore, fewer symptoms. If the increase in cT4 tumours is, in fact, a sign of stage migration due to diagnostic delay will become evident during the following years. Our study showed no difference in complication rate, ICU care, or 30-day mortality. This is in line with reports from Spain, where surgery was delayed but complications and mortality remained unchanged [24] . An international cohort study representing 40 countries, showed a higher 30-day mortality rate during the COVID-19 pandemic, but fewer anastomotic leakages. The mortality in case of anastomotic leakage was higher during the pandemic compared to the prepandemic period [23] . During the first wave of the COVID-19 pandemic, Sweden experienced a 9% reduction in overall cancer cases and a general reduction in patients seeking care for other conditions than COVID-19 [16]. The Swedish National Board of Health and Welfare published guidelines with the aim to guide physicians in prioritizing. All patients were to have an assessment of their condition. After the assessment, care could be delayed, but not for conditions that were assumed to have a large impact on life span or quality of life, that is, cancer care was prioritized [25] . This may explain why the quality of colon cancer treatment seems to have been maintained. An Australian review including data from 20 countries reported a 30% reduction in health care seeking during the pandemic [26] . For colon cancer patients in Sweden, the disruptions seem to have been mild. There was mainly a delay in diagnosis and treatment during the first wave of the pan- Days of hospital stay c median (IQR) 6 (4-10) 6 (4-9) 6 (4-9) 5 (3-8) 5 (3) (4) (5) (6) (7) (8) 0.17 ostomies, which may have future implications for quality of life in these patients. All authors have nothing to declare. All authors. The study was approved by the Regional Ethics committee in Stockholm (Dnr 2020-04169). Since this was a strictly registerbased study, individual informed consent was not required. KE and ÅHE had full access to data. Karolina Eklöv https://orcid.org/0000-0001-5059-5856 The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study Insights from a global snapshot of the change in elective colorectal practice due to the COVID-19 pandemic Surgical management of oncologic patient during and after the COVID-19 outbreak: practical recommendations from the Italian society of surgical oncology The challenges in colorectal cancer management during COVID-19 epidemic Cancer diagnostic rates during the 2020 'lockdown', due to COVID-19 pandemic, compared with the 2018-2019: an audit study from cellular pathology COVID-19 and the global impact on colorectal practice and surgery The challenges of urgent radical sigmoid colorectal cancer resection in a COVID-19 patient: a case report Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study Impact of the COVID-19 Pandemic on Surgical Treatment Patterns for Colorectal Cancer in a Tertiary Medical Facility in Korea Impact of the COVID-19 pandemic during Spain's state of emergency on the diagnosis of colorectal cancer Analys av första och andra covid-19-vågenproduktion, köer och väntetider i vården Uppskjuten cancervård -Jämförelse av antalet nyregistrerade cancerfall under covid-19-pandemin 2020 och motsvarande period 2019 The REporting of studies conducted using observational routinely-collected health data (RECORD) statement The public-private pendulum -patient choice and equity in Sweden Swedish nationel guidelines for CRC temporarily during covid 19 pandemic 2020 Family history of colorectal cancer and survival: a Swedish population-based study Evaluation of the Swedish colorectal cancer registry: an overview of completeness, timeliness, comparability and validity Experiences with the standardized classification of surgical complications (Clavien-Dindo) in general surgery patients Effect of the COVID-19 pandemic on colorectal cancer care in France The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand-a country pursuing COVID-19 elimination Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic. Colorectal Dis. 2020. Epub ahead of print The impact of SARS-CoV-2 infection on the surgical management of colorectal cancer: lessons learned from a multicenter study in Spain Nationella principer för prioritering av rutinsjukvård under covid-19-pandemin 2020 Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review